v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 5,591 $ 11,909
Restricted deposit 359 248
Trade receivables, net 1 150
Inventories 573 440
Other accounts receivable and prepaid expenses 223 433
Total current assets 6,747 13,180
Non-current assets:    
Restricted deposit 76 118
Operating lease right-of-use assets 2,426 2,991
Property and equipment, net 1,463 2,290
Intangible assets, net 73 131
Total non-current assets 4,038 5,530
Total assets 10,785 18,710
Current liabilities:    
Trade payables 610 870
Operating lease liabilities 814 806
Accrued liabilities and other payables 1,248 1,294
Total current liabilities 2,672 2,970
Non-current liabilities:    
Operating lease liabilities 2,032 2,275
Total non-current liabilities 2,032 2,275
Total liabilities 4,704 5,245
Commitments and contingencies
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2025 and 2024; issued and outstanding: 12,803,006 and 11,454,512 ordinary shares as of December 31, 2025 and 2024, respectively 5,492 4,983
Additional paid in capital 126,397 122,801
Accumulated other comprehensive loss (969) (969)
Accumulated deficit (124,839) (113,350)
Total shareholders’ equity 6,081 13,465
Total liabilities and shareholders’ equity $ 10,785 $ 18,710

Source